Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 5
1987 4
1988 1
1989 1
1990 5
1991 4
1992 1
1993 1
1994 5
1995 5
1996 7
1997 5
1998 2
1999 5
2000 4
2001 4
2002 5
2003 6
2004 4
2005 2
2006 6
2007 4
2008 2
2009 5
2010 1
2011 7
2012 5
2013 3
2014 4
2015 2
2016 4
2017 5
2018 3
2019 5
2020 5
2021 5
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

138 results

Results by year

Filters applied: . Clear all
Page 1
Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III trial.
Pujade-Lauraine E, Hilpert F, Weber B, Reuss A, Poveda A, Kristensen G, Sorio R, Vergote I, Witteveen P, Bamias A, Pereira D, Wimberger P, Oaknin A, Mirza MR, Follana P, Bollag D, Ray-Coquard I. Pujade-Lauraine E, et al. Among authors: sorio r. J Clin Oncol. 2014 May 1;32(13):1302-8. doi: 10.1200/JCO.2013.51.4489. Epub 2014 Mar 17. J Clin Oncol. 2014. PMID: 24637997 Clinical Trial.
Crivellari D, Toffoli G, Lombardi D, Berretta M, Sorio R, Magri MD, Spazzapan S, Scuderi C, Veronesi A. Crivellari D, et al. Among authors: sorio r. Tumori. 2002 Jan-Feb;88(1 Suppl 1):S73-4. doi: 10.1177/030089160208800122. Tumori. 2002. PMID: 11989932 No abstract available.
Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial.
Pignata S, Scambia G, Katsaros D, Gallo C, Pujade-Lauraine E, De Placido S, Bologna A, Weber B, Raspagliesi F, Panici PB, Cormio G, Sorio R, Cavazzini MG, Ferrandina G, Breda E, Murgia V, Sacco C, Cinieri S, Salutari V, Ricci C, Pisano C, Greggi S, Lauria R, Lorusso D, Marchetti C, Selvaggi L, Signoriello S, Piccirillo MC, Di Maio M, Perrone F; Multicentre Italian Trials in Ovarian cancer (MITO-7); Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens et du sein (GINECO); Mario Negri Gynecologic Oncology (MaNGO); European Network of Gynaecological Oncological Trial Groups (ENGOT-OV-10); Gynecologic Cancer InterGroup (GCIG) Investigators. Pignata S, et al. Among authors: sorio r. Lancet Oncol. 2014 Apr;15(4):396-405. doi: 10.1016/S1470-2045(14)70049-X. Epub 2014 Feb 28. Lancet Oncol. 2014. PMID: 24582486 Clinical Trial.
'Genetic profiling' and ovarian cancer therapy (review).
Vella N, Aiello M, Russo AE, Scalisi A, Spandidos DA, Toffoli G, Sorio R, Libra M, Stivala F. Vella N, et al. Among authors: sorio r. Mol Med Rep. 2011 Sep-Oct;4(5):771-7. doi: 10.3892/mmr.2011.512. Epub 2011 Jun 17. Mol Med Rep. 2011. PMID: 21687948 Review.
Machine Learning Application Identifies Germline Markers of Hypertension in Patients With Ovarian Cancer Treated With Carboplatin, Taxane, and Bevacizumab.
Polano M, Bedon L, Dal Bo M, Sorio R, Bartoletti M, De Mattia E, Cecchin E, Pisano C, Lorusso D, Lissoni AA, De Censi A, Cecere SC, Scollo P, Marchini S, Arenare L, De Giorgi U, Califano D, Biagioli E, Chiodini P, Perrone F, Pignata S, Toffoli G. Polano M, et al. Among authors: sorio r. Clin Pharmacol Ther. 2023 Sep;114(3):652-663. doi: 10.1002/cpt.2960. Epub 2023 Jun 21. Clin Pharmacol Ther. 2023. PMID: 37243926
Can visual capture of sound separate auditory streams?
Valzolgher C, Giovanelli E, Sorio R, Rabini G, Pavani F. Valzolgher C, et al. Among authors: sorio r. Exp Brain Res. 2022 Mar;240(3):813-824. doi: 10.1007/s00221-021-06281-8. Epub 2022 Jan 20. Exp Brain Res. 2022. PMID: 35048159
Treatment of older breast cancer patients with high recurrence risk.
Crivellari D, Spazzapan S, Lombardi D, Berretta M, Magri MD, Sorio R, Scalone S, Veronesi A. Crivellari D, et al. Among authors: sorio r. Crit Rev Oncol Hematol. 2003 Jun;46(3):241-6. doi: 10.1016/s1040-8428(03)00023-4. Crit Rev Oncol Hematol. 2003. PMID: 12791423 Review.
138 results